Case report of PET/CT imaging of a patient with neuroblastoma using18F-FPBG

Pediatrics

Volumn 134, Issue 6, 2014, Pages e1731-e1734

  Suh, Minseok ^a   Park, Hyo Jin ^a   Choi, Hyoung Soo ^a   So, Young ^b   Lee, Byung Chul ^a   Lee, Won Woo ^a,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Fluoropropylbenzylguanidine; Metaiodobenzylguanidine; Neuroblastoma; Positron emission tomography

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROPROPYLBENZYLGUANIDINE F18; ISOTRETINOIN; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (3 IODOBENZYL)GUANIDINE; GUANIDINE DERIVATIVE;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; BONE SCINTISCANNING; BRAIN FUNCTION; BRAIN SURGERY; CANCER RECURRENCE; CASE REPORT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MATHEMATICAL ANALYSIS; METASTASIS POTENTIAL; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PET SCANNER; RADIATION DOSE; STANDARDIZED UPTAKE VALUE; SYMPATHETIC NERVE; TIBIA; ADRENAL GLAND NEOPLASMS; BIOPSY; BONE MARROW; BONE NEOPLASMS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MULTIMODAL IMAGING; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADRENAL GLAND NEOPLASMS; BIOPSY; BONE MARROW; BONE NEOPLASMS; GUANIDINES; HUMANS; MALE; MULTIMODAL IMAGING; NEOPLASMS, MULTIPLE PRIMARY; NEUROBLASTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84913533561     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1872     Document Type: Article

References (15)

1. 131I]iodobenzylguanidine. J Nucl Med. 1980;21(4):349-353
2. Ackery DM, Tippett PA, Condon BR, Sutton HE, Wyeth P. New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine. Br Med J (Clin Res Ed). 1984;288(6430):1587-1591
3. DuBois SG, Matthay KK. Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma. Nucl Med Biol. 2008;35(suppl 1):S35-S48
4. Matthay KK, Quach A, Huberty J, et al. Iodine-131 - metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study. J Clin Oncol. 2009;27(7):1020-1025
5. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988;78(5 pt 1):1192-1199
6. 123I]metaiodobenzylguanidine scintigraphy. Circulation. 1994;89(6):2843-2851
7. Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993;22(2):368-375
8. Raffel DM, Corbett JR, del Rosario RB, et al. Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med. 1996;37(12):1923-1931
9. Nguyen NT, DeGrado TR, Chakraborty P, Wieland DM, Schwaiger M. Myocardial kinetics of carbon-11-epinephrine in the isolated working rat heart. J Nucl Med. 1997;38(5):780-785
10. 18F] fluoroalkyl)benzylguanidines. Bioconjug Chem. 2004;15(1):104-111
11. Moroz MA, Serganova I, Zanzonico P, et al. Imaging hNET reporter gene expression with 124I-MIBG. J Nucl Med. 2007;48(5):827-836
12. 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography. Br J Radiol. 1992;65(777):787-791
13. Lee CL, Wahnishe H, Sayre GA, et al. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET. Med Phys. 2010;37(9):4861-4867
14. 131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model. Mol Imag Biol. 2012;14(6):735-742
15. A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma. ClinicalTrials.gov. Identifier: NCT02043899 Available at: http://clinicaltrials.gov/ct2/show/NCT02043899?term=i-124+MIBG&rank=2. Accessed August 15, 2014